Savara (SVRA) traded up 7.11 % during a 24 hours period ending at 07:43 AM Central Europe on Tuesday 27th. One Savara stock can currently be bought for about USD 4.52 on popular exchanges. Current supply of Savara stocks is 255.3 mn. Savara has a current market capitalization of USD 1.1 bn and approximately USD 15.6 mn worth of Savara was traded on exchanges in the last 24 hours. Since last month end, Savara has traded -10.85 % down. Simple moving average of last 200 days is at USD 5.41. The highest price of past 52 weeks was recorded at USD 7 on 12/12/2025. 52 weeks low was at USD 3.86 on 11/07/2025.
Here is how related stocks have performed in the past 24 hours:
Community (CTBI) traded up 0.03 % and now trades at USD 70.52. Current market capitalisation for Community is USD 1.3 bn. Current price/earnings ratio for Community is 11.66.
Preferred Bank/los Angeles (PFBC) traded down -0.59 % and now trades at USD 106.09. Current market capitalisation for Preferred Bank/los Angeles is USD 1.3 bn. Preferred Bank/los Angeles has a current price to earnings ratio of 9.77.
Nektar Therapeutics (NKTR) traded up 0.62 % and now trades at USD 37.45. Current market capitalisation for Nektar Therapeutics is USD 1.3 bn.
Turning Point Brands (TPB) traded up 2.02 % and now trades at USD 65.28. Turning Point Brands has a market capitalisation of USD 1.3 bn. Turning Point Brands has a current price to earnings ratio of 28.02.
Taysha Gene Therapies (TSHA) traded up 1.26 % and now trades at USD 4.01. Taysha Gene Therapies has a market capitalisation of USD 1.3 bn.
About Savara
Savara Inc. is a clinical-stage pharmaceutical company specializing in the development of novel therapies for the treatment of rare respiratory diseases that can be life-threatening. The company operates globally, offering its services in biotechnology to combat serious respiratory afflictions.
